Tower Research Capital (TRC)’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,901
Closed -$2.57K 5632
2025
Q4
$2.57K Buy
1,901
+1,179
+163% +$1.19K ﹤0.01% 4501
2025
Q3
$874 Buy
722
+657
+1,011% +$539 ﹤0.01% 4917
2025
Q2
$58 Hold
65
﹤0.01% 5187
2025
Q1
$119 Buy
65
+1
+2% +$4 ﹤0.01% 5018
2024
Q4
$192 Sell
64
-2
-3% -$7 ﹤0.01% 5385
2024
Q3
$250 Sell
66
-1
-1% -$4 ﹤0.01% 5411
2024
Q2
$317 Buy
+67
New +$418 ﹤0.01% 5361
2023
Q2
Sell
-42
Closed -$3K 6401
2023
Q1
$3K Hold
42
﹤0.01% 5257
2022
Q4
$3K Buy
42
+4
+11% +$403 ﹤0.01% 5251
2022
Q3
$3K Buy
+38
New +$5.45K ﹤0.01% 5443
2022
Q2
Hold
0
6583
2022
Q1
Sell
-21
Closed -$7.09K 6606
2021
Q4
$8K Buy
21
+4
+24% +$2.33K ﹤0.01% 4835
2021
Q3
$13K Buy
17
+11
+183% +$9.21K ﹤0.01% 4106
2021
Q2
$6K Buy
+6
New +$7.18K ﹤0.01% 4648
2021
Q1
Sell
-13
Closed -$13K 5776
2020
Q4
$13K Buy
13
+7
+117% +$6.36K ﹤0.01% 4169
2020
Q3
$4K Sell
6
-21
-78% -$20K ﹤0.01% 4447
2020
Q2
$18K Buy
27
+13
+93% +$5.83K ﹤0.01% 3745
2020
Q1
$5K Buy
14
+12
+600% +$4.73K ﹤0.01% 2323
2019
Q4
$2K Buy
+2
New +$2.4K ﹤0.01% 3127
2019
Q3
Sell
-5
Closed -$11K 4568
2019
Q2
$11K Buy
+5
New +$10.1K ﹤0.01% 2522

Other funds holding YCBD

Tower Research Capital (TRC)'s YCBD Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of cbdMD (YCBD) in Q1 2026, closing a stake of 1,901 shares — an estimated $2.57K sold.

Tower Research Capital (TRC) first reported a position in YCBD in Q2 2019 and held it in 19 quarters. The position peaked at $18K in Q2 2020. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining cbdMD position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,901 cbdMD shares in Q1 2026, an estimated $2.57K.
  • Tower Research Capital (TRC) first reported a position in cbdMD in Q2 2019 and held it in 19 quarters.
  • Tower Research Capital (TRC)'s cbdMD position peaked at $18K in Q2 2020.
  • 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.